Independent studies have established the role of FXR signaling and the gut microbiota in the onset of obesity, thus, warranting the investigation of the interplay between intestinal FXR and the gut microbiome composition. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.